Malin Corporation | Kostnadene For Salg



Cost Of Sales Endring Dato
Alaunos Therapeutics 0 18K 2024-09
ALKERMES USD 49.2M 12.92M 2025-03
Avita Medical AUD 2.28M 170K 2024-12
Eurofins Scientific SE EUR 2.74B 74.6M 2024-12
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
IQVIA Holdings USD 2.53B 49M 2025-03
Lonza CHF 1.94B 858M 2024-06
Malin Corporation EUR 15.4M 0 2020-12
Moderna USD 90M 456M 2025-03
Organon & Co USD 672M 24M 2025-03
Revvity USD 289.22M 27.87M 2025-03
Viatris USD 2.13B 12.1M 2024-12
Xeris Pharmaceuticals USD 9.48M 4.12M 2024-12



Malin Corporation Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.